Global Medical Reit INC

Chiron Real Estate Inc. announced the appointment of Matthew Whitlock as Chief Investment Officer and the transition of Alfonzo Leon to Strategic Advisor, effective August 3, 2026.

Chiron Real Estate Inc. has announced key executive appointments and entered into new employment agreements with its senior leadership team, effective July 16, 2026.

Chiron Real Estate Inc. has updated its investor presentation, detailing strategic portfolio repositioning, capital allocation, and recent transactions aimed at delivering higher returns on invested capital.

Chiron Real Estate Inc. has completed the sale of a seven-property inpatient rehabilitation hospital portfolio for $217 million, retaining a 15% interest in the acquiring joint venture.

Chiron Real Estate Inc. announced the acquisition of two senior housing communities for $248.9 million and the successful private placement of Series C Convertible Preferred Stock raising $100 million.

Chiron Real Estate Inc. has appointed industry veteran Charles Fitzgerald to its Board of Directors and declared its second quarter 2026 preferred stock dividends.

Chiron Real Estate Inc. reported a net income decrease for Q1 2026 compared to Q1 2025, alongside significant strategic acquisitions and a dividend modification.

Global Medical REIT Inc. reported a net loss for Q3 2025, driven by an impairment charge and increased interest expenses, while successfully extending significant debt maturities post-quarter.

Global Medical REIT Inc. reported increased net income for Q2 2025, driven by acquisitions, but reduced its common stock dividend to strengthen its balance sheet.

Global Medical REIT's Q1 2025 results show a slight decrease in revenue offset by gains on property sales, while the company addresses challenges from interest rate hikes and healthcare wage inflation.

Global Medical REIT's third-quarter results show a decrease in revenue and net income compared to the previous year, influenced by property dispositions and acquisitions.

Global Medical REIT reported a net loss for the second quarter of 2024, impacted by a property sale loss, while also navigating a complex economic environment.

Chiron Real Estate Inc. reported a net loss of $6.9 million for the fiscal year ended December 31, 2025, driven by significant property impairment charges and increased interest expenses, despite higher rental revenue.

Global Medical REIT's 2024 results reflect a complex environment with strategic dispositions, acquisitions, and leadership changes impacting financial performance.

Global Medical REIT Inc. released its 2023 annual report, detailing financial performance, strategic initiatives, and risk factors.

Robert Harold Zeiller, See Remarks of Global Medical REIT Inc., received 2,477 shares of common stock on July 16, 2026.

Director Charles Fitzgerald reported the acquisition of 220,000 shares of 6.00% Series C Convertible Preferred Stock in Chiron Real Estate Inc. via Maewyn XRN LP.

Director Lori Wittman was granted 2,497 LTIP units in Chiron Real Estate Inc. as part of the company's equity incentive plan.

Director Charles Fitzgerald of Chiron Real Estate Inc. was granted 4,700 LTIP units in lieu of cash director compensation.

Director Matthew Cypher was granted 2,497 LTIP units in Chiron Real Estate Inc. as part of the company's equity incentive plan.

Director Paula Crowley was granted 2,497 LTIP units in Chiron Real Estate Inc. as part of the company's equity incentive plan.

Chiron Real Estate Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on May 20, 2026, with key proposals including director elections and equity plan amendments.

Global Medical REIT Inc. has filed a definitive proxy statement with the SEC.

Global Medical REIT will hold its annual stockholder meeting virtually on May 14, 2025, to elect directors, approve executive compensation, and ratify the appointment of Deloitte & Touche LLP as its independent accounting firm.

Global Medical REIT Inc. will hold its annual meeting of stockholders virtually on May 15, 2024, to vote on director elections, executive compensation, an equity incentive plan amendment, and auditor ratification.

Global Medical REIT's annual stockholder meeting will be held virtually on May 15, 2024, to vote on director elections, executive compensation, and other corporate matters.

Vanguard Portfolio Management has reported beneficial ownership of 666,452 shares, representing 5.03% of Chiron Real Estate Inc.'s common stock.

The Vanguard Group has reported a complete divestment of its beneficial ownership in Chiron Real Estate Inc. due to an internal corporate realignment.

Prudential Financial, Inc. has filed an amendment to its beneficial ownership report, disclosing a 2.2% stake in Global Medical REIT Inc.

Prudential Financial Inc. has disclosed a 5.1% beneficial ownership stake in Global Medical REIT Inc. as of March 31, 2025, through a Schedule 13G filing.